Try a new search

Format these results:

Searched for:

school:SOM

Department/Unit:Child and Adolescent Psychiatry

Total Results:

11212


Informativeness of Self-Reports of ADHD Symptoms in Monitoring Response to Stimulant Treatment in Clinically Referred Adults With ADHD

Biederman, Joseph; Fitzgerald, Maura; Spencer, Thomas J; Adler, Lenard A; Abrams, Jessica; Biederman, Itai; Faraone, Stephen V
OBJECTIVE:To investigate the informativeness of self-reports of ADHD symptoms in adults with ADHD in the clinical setting. METHOD/METHODS:Subjects were clinically referred adults aged 19 years to 67 years of age of both sexes ( N = 54). All subjects were on stable doses of stimulant and were considered responders to treatment. ADHD symptoms were assessed using the ADHD Investigator Symptom Rating Scale (AISRS) and the ADHD Self-Report Scale (ASRS). Spearman's rank correlations were used to assess the correlations between clinician-assessed ADHD and patients' self-reports. RESULTS:Spearman's rank correlation analysis found evidence of a strong, positive association between total scores on the AISRS and the ASRS ( rs = .65, df = 52, p< .001). CONCLUSION/CONCLUSIONS:Results have important implications for the management and monitoring of treatment response in the clinical setting through patients' self-report.
PMID: 29804496
ISSN: 1557-1246
CID: 3136792

Perceptual and Executive Behavioral Deficits in ADHD and Their Differential Correlation With Microsaccade Rate [Meeting Abstract]

Mihali, Andra; Young, Allison G.; Adler, Lenard A.; Halassa, Michael; Ma, Wei Ji
ISI:000432466300500
ISSN: 0006-3223
CID: 3147712

Loudness Dependency of Auditory Evoked Potentials (LDAEP) as a Differential Predictor of Antidepressant Treatment Response in Major Depressive Disorder (MDD): Results From the Sertraline/Placebo-Controlled EMBARC Study [Meeting Abstract]

Kayser, Jurgen; Tenke, Craig E.; Petkova, Eva; Wong, Lidia Y. X.; Wickramaratne, Priya; Alschuler, Daniel M.; Alvarenga, Jorge E.; Abraham, Karen; Pechtel, Pia; Webb, Christian A.; Dillon, Daniel G.; Deldin, Patricia; Cooper, Crystal; Trombello, Joseph; McGrath, Patrick; Fava, Maurizio; Oquendo, Maria A.; Trivedi, Madhukar H.; Weissman, Myrna M.; Pizzagalli, Diego A.; Bruder, Gerard E.
ISI:000433001900381
ISSN: 0006-3223
CID: 3140402

Chemosensory Thalamus (Introduction abstract of the symposium) [Meeting Abstract]

Courtiol, Emmanuelle; Fontanini, Alfredo
ISI:000431236000019
ISSN: 0379-864x
CID: 3113832

β-Adrenergic enhancement of neuronal excitability in the lateral amygdala is developmentally gated

Fink, Ann E; LeDoux, Joseph E
Noradrenergic signaling in the amygdala is important for processing threats and other emotionally salient stimuli, and β-adrenergic receptor activation is known to enhance neuronal spiking in the lateral amygdala (LA) of juvenile animals. Nevertheless, intracellular recordings have not yet been conducted to determine the effect of β-adrenergic receptor activation on spike properties in the adult LA, despite the potential significance of developmental changes between adolescence and adulthood. Here we demonstrate that the β-adrenergic agonist isoproterenol (15 μM) enhances spike frequency in dorsal LA principal neurons of juvenile male C57BL/6 mice and fails to do so in strain- and sex-matched adults. Furthermore, we find that the age-dependent effect of isoproterenol on spike frequency is occluded by the GABAA receptor blocker picrotoxin (75 μM), suggesting that β-adrenergic receptors downregulate tonic inhibition specifically in juvenile animals. These findings indicate a significant shift during adolescence in the cellular mechanisms of β-adrenergic modulation in the amygdala. NEW & NOTEWORTHY β-Adrenergic receptors (β-ARs) in amygdala are important in processing emotionally salient stimuli. Most cellular recordings have examined juvenile animals, while behavioral data are often obtained from adults. We replicate findings showing that β-ARs enhance spiking of principal cells in the lateral amygdala of juveniles, but we fail to find this in adults. These findings have notable scientific and clinical implications regarding the noradrenergic modulation of threat processing, alterations of which underlie fear and anxiety disorders.
PMCID:6008094
PMID: 29361666
ISSN: 1522-1598
CID: 3202482

Is Increased Response Time Variability Related to Deficient Emotional Self-Regulation in Children With ADHD? [Meeting Abstract]

Elmaghrabi, Shereen; Nahmias, Maria; Adamo, Nicoletta; Di Martino, Adriana; Somandepalli, Krishna; Patel, Varun; McLaughlin, Andrea; De Sanctis, Virginia; Castellanos, Francisco
ISI:000432466300381
ISSN: 0006-3223
CID: 3147732

Evidence of Differential Changes in Cortical Thickness and Volume Between SSRI and Placebo Treated Patients With Major Depressive Disorder [Meeting Abstract]

Bartlett, Elizabeth; DeLorenzo, Christine; Sharma, Priya; Yang, Jie; Zhang, Mengru; Petkova, Eva; Weissman, Myrna; McGrath, Patrick; Fava, Maurizio; Ogden, Todd; Kurian, Benji; Malchow, Ashley; Cooper, Crystal; Trombello, Joseph; McInnis, Melvin; Adams, Phil; Oquendo, Maria; Pizzagalli, Diego; Trivedi, Madhukar; Parsey, Ramin
ISI:000432466300177
ISSN: 0006-3223
CID: 3147792

Receptor Protein Tyrosine Phosphatases in Schizophrenia [Meeting Abstract]

Malaspina, Dolores; Kranz, Thorsten; Gonen, Oded; Harrock, Sheila; Chao, Moses
ISI:000432466300173
ISSN: 0006-3223
CID: 3147802

Development of White Matter Circuitry in Infants With Fragile X Syndrome

Swanson, Meghan R; Wolff, Jason J; Shen, Mark D; Styner, Martin; Estes, Annette; Gerig, Guido; McKinstry, Robert C; Botteron, Kelly N; Piven, Joseph; Hazlett, Heather C
Importance:Fragile X syndrome (FXS) is a genetic neurodevelopmental disorder and the most common inherited cause of intellectual disability in males. However, there are no published data on brain development in children with FXS during infancy. Objective:To characterize the development of white matter at ages 6, 12, and 24 months in infants with FXS compared with that of typically developing controls. Design, Setting, and Participants:Longitudinal behavioral and brain imaging data were collected at 1 or more time points from 27 infants with FXS and 73 typically developing controls between August 1, 2008, and June 14, 2016, at 2 academic medical centers. Infants in the control group had no first- or second-degree relatives with intellectual or psychiatric disorders, including FXS and autism spectrum disorder. Main Outcomes and Measures:Nineteen major white matter pathways were defined in common atlas space based on anatomically informed methods. Diffusion parameters, including fractional anisotropy, were compared between groups using linear mixed effects modeling. Fiber pathways showing group differences were subsequently examined in association with direct measures of verbal and nonverbal development. Results:There were significant differences in the development of 12 of 19 fiber tracts between the 27 infants with FXS (22 boys and 5 girls) and the 73 infants in the control group (46 boys and 27 girls), with lower fractional anisotropy in bilateral subcortical-frontal, occipital-temporal, temporal-frontal, and cerebellar-thalamic pathways, as well as 4 of 6 subdivisions of the corpus callosum. For all 12 of these pathways, there were significant main effects between groups but not for the interaction of age × group, indicating that lower fractional anisotropy was present and stable from age 6 months in infants with FXS. Lower fractional anisotropy values in the uncinate fasciculi were correlated with lower nonverbal developmental quotient in the FXS group (left uncinate, F = 10.06; false discovery rate-corrected P = .03; right uncinate, F = 21.8; P = .004). Conclusions and Relevance:The results substantiate in human infants the essential role of fragile X gene expression in the early development of white matter. The findings also suggest that the neurodevelopmental effects of FXS are well established at 6 months of age.
PMCID:6026861
PMID: 29617515
ISSN: 2168-6238
CID: 4942402

Dynamic Changes in Risky Decision-Making Predict Imminent Heroin Use in Opioid Users Studied Longitudinally Through the First Months of Treatment [Meeting Abstract]

Konova, Anna; Lopez-Guzman, Silvia; Urmanche, Adelya; Ross, Stephen; Louie, Kenway; Rotrosen, John; Glimcher, Paul
ISI:000432466300077
ISSN: 0006-3223
CID: 3147812